Article info

Download PDFPDF

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

Authors

  • Jiao Wang Department of Industrial and Physical PharmacyPurdue University 575 Stadium Mall Drive, Robert E. Heine Pharmacy Building West Lafayette IN USA PubMed articlesGoogle scholar articles
  • Kyle B. Lupo Department of Industrial and Physical PharmacyPurdue University 575 Stadium Mall Drive, Robert E. Heine Pharmacy Building West Lafayette IN USA PubMed articlesGoogle scholar articles
  • Andrea M. Chambers Department of Industrial and Physical PharmacyPurdue University 575 Stadium Mall Drive, Robert E. Heine Pharmacy Building West Lafayette IN USA PubMed articlesGoogle scholar articles
  • Sandro Matosevic Department of Industrial and Physical PharmacyPurdue University 575 Stadium Mall Drive, Robert E. Heine Pharmacy Building West Lafayette IN USA Center for Cancer ResearchPurdue University 47907 West Lafayette IN USA PubMed articlesGoogle scholar articles
  1. d +1 765 494 1400 sandro{at}purdue.edu
View Full Text

Citation

Wang J, Lupo KB, Chambers AM, et al
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

Publication history

  • Received July 24, 2018
  • Accepted October 31, 2018
  • First published December 4, 2018.
Online issue publication 
December 04, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.